RxDoctor Payments Data

Donald Welker, MD

Family Medicine · Dearborn, MINPI 1023081460

Payments from drug & device makers

$2,482in general payments, 2019–2025

Across 131 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$463
  • Novo Nordisk$376
  • Pfizer$359
  • Exact Sciences$310
  • Lilly USA, LLC$182
  • AbbVie$180
  • plus $613 from 20 others

What the payments were for

  • Food & beverage$2,482100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,482 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$89,722
Medicare patients
252
Services billed
1,260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban87$103,741
OzempicSemaglutide50$51,578
TrulicityDulaglutide17$20,557
JardianceEmpagliflozin28$19,991
Breo ElliptaFluticasone/Vilanterol17$17,193
EntrestoSacubitril/Valsartan19$12,563
MounjaroTirzepatide12$12,426
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$11,447
LantusInsulin Glargine,hum.Rec.Anlog20$6,487
PaxlovidNirmatrelvir/Ritonavir23$4,193
Levothyroxine Sodium277$4,069
Atorvastatin Calcium221$3,211
Metoprolol Succinate163$2,693
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen158$2,683
Metformin Hcl227$2,671

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$359$107,935110 claims
Novo NordiskOzempic$376$51,57850 claims
Lilly USA, LLCTrulicity, Mounjaro$182$32,98329 claims
GSKBreo Ellipta, Trelegy Ellipta$31$28,64035 claims
Boehringer IngelheimJardiance$93$19,99128 claims
AbbVieSynthroid$180$68913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Dearborn

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →